Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Pediatric Bipolar Depression

ClinicalTrials.gov ID: NCT00811473

Public ClinicalTrials.gov record NCT00811473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 4:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An 8-week, Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended-Release in Children and Adolescent Subjects With Bipolar Depression

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine if quetiapine fumarate extended-release (quetiapine XR or SEROQUEL® XR) 150 to 300 mg/day taken by itself is effective and safe in treating children or adolescents aged 10 to 17 with bipolar depression and if so, how it compares with placebo (a non-active tablet, like a sugar pill, that looks like quetiapine).

Study identification

NCT ID
NCT00811473
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
193 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
10 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2009 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Jul 15, 2014

2009 – 2010

United States locations

U.S. sites
31
U.S. states
24
U.S. cities
31
Facility City State ZIP Site status
Research Site Dothan Alabama — —
Research Site Scottsdale Arizona — —
Research Site Little Rock Arkansas — —
Research Site Escondido California — —
Research Site Bradenton Florida — —
Research Site Gainsville Florida — —
Research Site North Miami Florida — —
Research Site Tampa Florida — —
Research Site Atlanta Georgia — —
Research Site Smyrna Georgia — —
Research Site Eagle Idaho — —
Research Site Hoffman Estates Illinois — —
Research Site Terre Haute Indiana — —
Research Site Overland Park Kansas — —
Research Site Wichita Kansas — —
Research Site Clinton Township Michigan — —
Research Site Minneapolis Minnesota — —
Research Site Flowood Mississippi — —
Research Site St Louis Missouri — —
Research Site Lincoln Nebraska — —
Research Site Rochester New York — —
Research Site Cincinnati Ohio — —
Research Site Cleveland Ohio — —
Research Site Mason Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Charleston South Carolina — —
Research Site Memphis Tennessee — —
Research Site Wharton Texas — —
Research Site Virginia Beach Virginia — —
Research Site Bothell Washington — —
Research Site Milwaukee Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00811473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 15, 2014 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00811473 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →